Globe Life reported total revenue of $1.60 billion for the third quarter, surpassing analyst estimates of $1.56 billion. Net operating income of $4.84 per share was slightly below expectations as the company lowered its full-year 2026 earnings guidance to reflect one-time claims pressures in its health segment and administrative processing delays.
Key Highlights
- Total premium revenue increased 7% year-over-year to $1.31 billion, anchored by 16% growth in the health insurance segment.
- A $16 million underwriting loss at the developing Evry health unit and $7 million in excess claims due to CMS processing delays at United American pressured margins.
- Management raised its full-year common stock repurchase target to between $725 million and $775 million, up from the previous $670–$700 million range.
- Sales productivity was mixed across divisions, with Liberty National agent counts rising 9% while American Income Life agents decreased by 7%.